Correlation Between Icosavax and Vaccinex
Can any of the company-specific risk be diversified away by investing in both Icosavax and Vaccinex at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Icosavax and Vaccinex into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Icosavax and Vaccinex, you can compare the effects of market volatilities on Icosavax and Vaccinex and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Icosavax with a short position of Vaccinex. Check out your portfolio center. Please also check ongoing floating volatility patterns of Icosavax and Vaccinex.
Diversification Opportunities for Icosavax and Vaccinex
Pay attention - limited upside
The 3 months correlation between Icosavax and Vaccinex is 0.0. Overlapping area represents the amount of risk that can be diversified away by holding Icosavax and Vaccinex in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Vaccinex and Icosavax is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Icosavax are associated (or correlated) with Vaccinex. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Vaccinex has no effect on the direction of Icosavax i.e., Icosavax and Vaccinex go up and down completely randomly.
Pair Corralation between Icosavax and Vaccinex
Given the investment horizon of 90 days Icosavax is expected to generate 0.79 times more return on investment than Vaccinex. However, Icosavax is 1.27 times less risky than Vaccinex. It trades about 0.0 of its potential returns per unit of risk. Vaccinex is currently generating about -0.08 per unit of risk. If you would invest 1,072 in Icosavax on November 2, 2024 and sell it today you would lose (170.00) from holding Icosavax or give up 15.86% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Flat |
| Strength | Insignificant |
| Accuracy | 23.68% |
| Values | Daily Returns |
Icosavax vs. Vaccinex
Performance |
| Timeline |
| Icosavax |
Risk-Adjusted Performance
0 of 100
Weak | Strong |
Very Weak
| Vaccinex |
Risk-Adjusted Performance
0 of 100
Weak | Strong |
Very Weak
Icosavax and Vaccinex Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Icosavax and Vaccinex
The main advantage of trading using opposite Icosavax and Vaccinex positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Icosavax position performs unexpectedly, Vaccinex can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Vaccinex will offset losses from the drop in Vaccinex's long position.| Icosavax vs. Terns Pharmaceuticals | Icosavax vs. Amylyx Pharmaceuticals | Icosavax vs. Acumen Pharmaceuticals | Icosavax vs. Inozyme Pharma |
| Vaccinex vs. Protara Therapeutics | Vaccinex vs. Monopar Therapeutics | Vaccinex vs. Surrozen | Vaccinex vs. Salarius Pharmaceuticals |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Center module to all portfolio management and optimization tools to improve performance of your portfolios.
Other Complementary Tools
| Alpha Finder Use alpha and beta coefficients to find investment opportunities after accounting for the risk | |
| Funds Screener Find actively-traded funds from around the world traded on over 30 global exchanges | |
| Bond Analysis Evaluate and analyze corporate bonds as a potential investment for your portfolios. | |
| Options Analysis Analyze and evaluate options and option chains as a potential hedge for your portfolios | |
| Content Syndication Quickly integrate customizable finance content to your own investment portal |